~~<i id='D65ACB9903'><strike id='D65ACB9903'><tt id='D65ACB9903'><pre id='D65ACB9903'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

comprehensive

author：fashion 2025-09-28 23:11:51 - browse：8

JOHNSON & JOHNSON HEADQUARTERS — Daniel Hulshizer/AP

Eight months into his tenure, Johnson & Johnson’s R&D chief is putting a big emphasis on medicines for cancer, treatment-resistant depression, and autoimmune disease.

To sharpen that focus, R&D chief John Reed told STAT that the company is de-emphasizing two areas that have been mainstays for the drug and medical device giant: infectious disease and vaccines, as well as medicines targeting kidney disease and rare eye conditions.

The disclosures were made in an interview ahead of an investor meeting Reed is leading Tuesday aimed at generating excitement about the company’s research and development efforts.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： STAT Virtual Event: ASCO Recap, Live!

explore

hotspot

focus

Wikipedia

leisure time

Michel,acysticfibrosispatientfromMascouche,Québec,Canada,seenhereatoneoftheclinicsthatcontributeddat

WSS

How faith leaders like me can help address America's obesity epidemic

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Lilly's Alzheimer's drug donanemab backed by FDA advisers

California wildfire smoke linked to 52,000 early deaths, study says

Medical device trials still don't enroll enough women, study finds

leisure time

comprehensive

explore

In age of alternative facts, a scholarly course on calling out crap

Lupron, used to halt puberty in children, may cause lasting health problems

Moonlake's readout produced a cash windfall. Risks remain

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Virginia high school admissions case could be legal follow

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Drug cartel violence flares in western Mexico after vigilante leader's killing

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

NIH tests clinical research in primary care with $30 million program

hotspot

Security flaws in third

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Beware reading your test results before your doctor does

Drug cartel violence flares in western Mexico after vigilante leader's killing

Medical device trials still don't enroll enough women, study finds

STAT wants to know your pick for a great summer read or listen

hotspot

focus

Wikipedia

leisure time